Beam Therapeutics Inc. · NASDAQ:BEAM

Evans John M. sold 50,000 Beam Therapeutics Inc. shares (Form 4)

Traded Mar 30 to Mar 31, 2026 · Filed Apr 1, 2026

From Mar 30 to Mar 31, 2026, Evans John M. (Director, CEO) sold 50,000 Beam Therapeutics Inc. shares at an average US$22.57 for US$1.13M under a trading plan, leaving 1,076,667 shares. Filed Apr 1, 2026 (Form 4).

Sold: 50,000 shares
Price: US$22.57 average (US$22.37 to US$22.76)
Value: US$1.13M
Holding after: 1,076,667 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Director, CEO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Mar 30, 2026	Common Stock	Option exercise	25,000	US$0.67	1,011,667	Direct
Mar 30, 2026	Common Stock	Sale	25,000	US$22.37	986,667	Direct
Mar 31, 2026	Common Stock	Option exercise	25,000	US$0.67	1,011,667	Direct
Mar 31, 2026	Common Stock	Sale	25,000	US$22.76	986,667	Direct
Mar 31, 2026	Common Stock	Award	90,000		1,076,667	Direct

Source

View original at SEC

Related